Baudax Bio Announces Publication of Phase IIIb Data on Preoperative Administration of ANJESO® in Patients Undergoing Total Knee Arthroplasty (TKA) in Pain Medicine Apr 26, 2021 7:00am EDT
Baudax Bio to Participate at the Oppenheimer 31st Annual Healthcare Conference Mar 10, 2021 7:00am EST
Baudax Bio Strengthens Management Team with Appointment of Richard S. Casten as Chief Financial Officer Mar 08, 2021 7:00am EST
Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16, 2021 Feb 10, 2021 8:04am EST
Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules Feb 08, 2021 3:24pm EST
Baudax Bio Announces Exercise of Warrants for Gross Proceeds of $13.4 Million Jan 21, 2021 9:28am EST
